Mycronic AB (publ) (STO:MYCR)
| Market Cap | 60.77B +60.3% |
| Revenue (ttm) | 8.30B +10.6% |
| Net Income | 1.66B -8.8% |
| EPS | 8.47 -8.9% |
| Shares Out | 195.27M |
| PE Ratio | 36.74 |
| Forward PE | 36.80 |
| Dividend | 3.25 (1.04%) |
| Ex-Dividend Date | May 7, 2026 |
| Volume | 333,402 |
| Open | 313.40 |
| Previous Close | 312.40 |
| Day's Range | 306.20 - 313.40 |
| 52-Week Range | 174.00 - 313.40 |
| Beta | 0.72 |
| Analysts | Hold |
| Price Target | 260.25 (-16.37%) |
| Earnings Date | Jul 14, 2026 |
About Mycronic AB
Mycronic AB (publ) develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. It operates through four segments: Pattern Generators, PCB Assembly, High-Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and metrology systems for display manufacturing and production of semiconductors. The PCB Assembly segment develops, manufactures, and markets flex... [Read more]
Financial Performance
In 2025, Mycronic AB's revenue was 7.94 billion, an increase of 12.48% compared to the previous year's 7.06 billion. Earnings were 1.56 billion, a decrease of -7.31%.
Financial StatementsNews
Mycronic AB Earnings Call Transcript: Q1 2026
Q1 delivered record sales and EBIT, driven by strong demand in High Volume and Global Technologies, leading to an upgraded 2026 sales outlook. Pattern Generators saw robust sales but lower order intake, while PCB Assembly Solutions remained weak. AI and OLED trends continue to support growth.
Mycronic AB Quarterly report: Q1 2026
Mycronic AB has published its Q1 2026 quarterly earnings report on April 24, 2026.
Mycronic AB Slides: Q1 2026
Mycronic AB has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 24, 2026.
Mycronic AB Earnings Call Transcript: Q4 2025
Order intake declined 19% year-over-year, but sales remained flat as strong growth in Global Technologies offset declines elsewhere. EBIT margin was 17% for the quarter, with continued R&D investment and a positive outlook for Global Technologies and High Volume divisions.
Mycronic AB Annual report: Q4 2025
Mycronic AB has published its Q4 2025 annual report on February 5, 2026.
Mycronic AB Quarterly report: Q4 2025
Mycronic AB has published its Q4 2025 quarterly earnings report on February 5, 2026.
Mycronic AB Slides: Q4 2025
Mycronic AB has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 5, 2026.
Mycronic AB Earnings Call Transcript: Q3 2025
Order intake surged 67% year-over-year, led by Pattern Generators and Global Technologies, while sales dipped 4% and EBIT margin fell to 15% due to product mix. Backlog and cash remain strong, with continued M&A activity and a positive full-year outlook.
Mycronic AB Quarterly report: Q3 2025
Mycronic AB has published its Q3 2025 quarterly earnings report on October 23, 2025.
Mycronic AB Slides: Q3 2025
Mycronic AB has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 23, 2025.
Mycronic AB Earnings Call Transcript: Q2 2025
Q2 saw 35% sales growth and a 27% EBIT margin, with strong performance in Pattern Generators and High Volume, but order intake declined due to no new system orders. Three acquisitions and a share split were completed, and full-year sales guidance was reaffirmed at SEK 7.5 billion.
Mycronic AB Quarterly report: Q2 2025
Mycronic AB has published its Q2 2025 quarterly earnings report on July 11, 2025.
Mycronic AB Slides: Q2 2025
Mycronic AB has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 11, 2025.